|Day Low/High||84.57 / 86.16|
|52 Wk Low/High||79.13 / 106.74|
For the third consecutive year, BioMarin ranks in top 10 on list
BioMarin (BMRN) stock was trading sharply higher this morning after Pfizer (PFE) beat out Sanofi (SNY) to purchase Medivation (MDVN).
Overall, this is still a good environment for stock picking.
They're striking while the iron is hottest to raise money, reduce debt.
BioMarin (BMRN) stock is trading lower after the market close after announcing a public offering of common stock.
That may be the best way to get through the notorious month of August.
BMN 270 is one of the most important drugs in Biomarin's research pipeline and key driver of future revenue and earnings.
Conference call and web-cast to be held Wednesday, July 27th at 4:05pm ET
The Swiss pharmaceuticals company confirms a forecast for full-year sales to increase in the low to mid-single digits, and for earnings per share to grow faster than revenue.
TheStreet highlights 3 stocks pushing the drugs industry higher today.
All of these add up to a level of insecurity on the part of sidelined money.
Trade-Ideas LLC identified Biomarin Pharmaceutical (BMRN) as a "storm the castle" (crossing above the 200-day simple moving average on higher than normal relative volume) candidate
A sharp selloff in crude kept stocks mostly in the red, though optimism ahead of Friday's jobs reports kept losses to a minimum on Thursday.
BioMarin (BMRN) stock is trading sharply higher this morning following reports that Roche (RHHBY) could pursue a takeover.
Trade-Ideas LLC identified Biomarin Pharmaceutical (BMRN) as a pre-market mover with heavy volume candidate
A call with investors Wednesday highlights drugs in the pipeline that could be attractive to bidders that reportedly include Sanofi, Pfizer and Celgene, among others.
TheStreet's Adam Feuerstein answers reader questions about biotech stocks.
Besides Sanofi, Biogen is the next most likely to complete a sizable transaction in the next 12 months, according to Credit Suisse analysts.
The U.S. woke up today to the news of a "Brexit" win, which has sent global markets reeling.
Investor event to be held in Orlando following the July 27 oral presentation at the WFH meeting
Biotech company BioMarin Pharmacuetical's shares are moving sharply higher on heavy volume in Friday's session.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.